Drug Type Small molecule drug |
Synonyms 左氨氯地平比索洛尔 |
Action blockers, antagonists |
Mechanism L-type calcium channel blockers(Voltage-gated L-type calcium channel blockers), β1-adrenergic receptor antagonists(Beta-1 adrenergic receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseNDA/BLA |
First Approval Date- |
Regulation- |
Molecular FormulaC24H29ClN2O9 |
InChIKeyTZNOWAJJWCGILX-HNUXRKMMSA-N |
CAS Registry135969-53-8 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Essential Hypertension | NDA/BLA | China | 28 Apr 2025 |





